The Fecal Calprotectin Test Market Size was valued at USD 140.2 Mn in 2023 and is predicted to reach USD 280.5 Mn by 2031 at a 9.17% CAGR during the forecast period for 2024-2031.
Fecal calprotectin testing can identify gastrointestinal inflammation. A protein called calprotectin is secreted by white blood cells when inflammation occurs. Several factors drive the global fecal calprotectin test industry forward, including healthcare providers' and patients' growing recognition of non-invasive testing procedures. The diagnostic tools market is being driven by technological improvements that improve the accuracy and efficiency of tests. Another factor driving the popularity of fecal calprotectin tests is the growing availability of home testing kits and the focus on preventative healthcare.
The factor fueling the global rise of the fecal calprotectin test market is the cooperation between research organizations, academic institutions, and industry players. Moreover, companies in the fecal calprotectin test industry work with medical professionals, labs specialising in diagnostics, and universities to create and sell cutting-edge testing products. Overall, the industry is growing due to these alliances, which boost product innovation, guarantee regulatory compliance, and increase market growth.
However, the high cost of testing and the lack of knowledge among patients and healthcare providers are the main factors limiting the market for fecal calprotectin tests, preventing their widespread acceptance and accessibility. In addition, the fecal calprotectin test market was affected by the COVID-19 pandemic because it limited patient visits to healthcare institutions and caused delays in standard diagnostic processes. However, the market was able to bounce back because of rising demand for non-invasive home testing kits and persistent emphasis on early diagnosis and management of gastrointestinal diseases. Market growth is attributable to increasing investments and technological developments in the fecal calprotectin test market.
The fecal calprotectin test market is segmented based on patient type, assay type, indication, and end-user. Based on patient type, the market is segmented into adult and pediatric. The market is segmented by assay type into ELISA (Enzyme-linked Immunosorbent Assay), enzyme fluoroimmunoassay, and quantitative immune chromatography. By indication, the market is segmented into inflammatory bowel disease, colorectal cancer, and celiac disease. The market is segmented by end-user into hospitals, diagnostic laboratories, and academic & research institutes.
The adult fecal calprotectin test market is expected to hold a major global market share in 2023 due to the great frequency of adult gastrointestinal disorders, including ulcerative colitis and Crohn’s disease. Early diagnosis and growing knowledge of these diseases fuel the need for non-invasive diagnostic approaches. Further driving of this segment development includes the increasing frequency of colorectal cancer screenings and the need to monitor chronic inflammatory bowel illnesses efficiently.
Diagnostic laboratories are growing because there is a growing need for non-invasive diagnostic instruments that can accurately identify gastrointestinal illnesses. Having trustworthy testing procedures is crucial due to the increasing number of cases of Crohn’s disease, ulcerative colitis, and colon cancer. Additionally, diagnostic laboratories that offer fecal calprotectin tests are on the rise, which is a good thing because diagnostic laboratory technology is always improving and because people are starting to pay more attention to the importance of early diagnosis and preventative healthcare, growing this segment.
The North American fecal calprotectin test market is expected to register the highest market share in revenue in the near future because of improvements in healthcare, a rise in the number of gastrointestinal illnesses, and a greater emphasis on the need for early detection. The presence of top diagnostic firms and heavy investment in R&D also contribute to the region’s booming market. In addition, Asia Pacific is projected to grow rapidly in the global fecal calprotectin test market because of the widespread nature of gastrointestinal problems, the ever-increasing cost of healthcare, and the expanding knowledge of alternatives to invasive diagnostic procedures.
Moreover, contributing to the region’s market growth are expanding healthcare infrastructure and large investments in medical research in the Asia Pacific region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 140.2 Mn |
|
Revenue Forecast In 2031 |
USD 280.5 Mn |
|
Growth Rate CAGR |
CAGR of 9.17% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Patient Type, By Assay Type, By Indication, By End-user and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Abbexa, ALPCO, Alpha Laboratories, Biomerica, BÜHLMANN Laboratories AG, DRG INSTRUMENTS GMBH, EagleBio, Epitope Diagnostics, Inc., OPERON, S.A., R-Biopharm AG, Svar Life Science, Thermo Fisher Scientific, Inc., Werfen, SENTINEL CH. SpA, Diazyme Laboratories, Inc., and DiAgam. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fecal Calprotectin Test Market Snapshot
Chapter 4. Global Fecal Calprotectin Test Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Patient Type Estimates & Trend Analysis
5.1. By Patient Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Patient Type:
5.2.1. Adult
5.2.2. Pediatric
Chapter 6. Market Segmentation 2: By Assay Type Estimates & Trend Analysis
6.1. By Assay Type & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Assay Type:
6.2.1. ELISA (Enzyme linked Immunosorbent Assay)
6.2.2. Enzyme Fluoroimmunoassay
6.2.3. Quantitative Immune-chromatography
Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis
7.1. By Indication & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Indication:
7.2.1. Inflammatory Bowel Disease
7.2.2. Colorectal Cancer
7.2.3. Celiac Disease
Chapter 8. Market Segmentation 4: by End User Estimates & Trend Analysis
8.1. by End User & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
8.2.1. Hospitals
8.2.2. Diagnostic Laboratories
8.2.3. Academic & Research Institutes
Chapter 9. Fecal Calprotectin Test Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.1.2. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.1.3. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.1.4. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.1.5. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.2.2. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.2.3. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.2.4. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.2.5. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.3.2. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.3.3. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.3.4. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.3.5. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.4.2. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.4.3. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.4.4. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.4.5. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.5.2. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.5.3. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.5.4. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.5.5. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Abbexa
10.2.2. ALPCO
10.2.3. Alpha Laboratories
10.2.4. Biomerica
10.2.5. BÜHLMANN Laboratories AG
10.2.6. DRG Instruments GmbH
10.2.7. EagleBio
10.2.8. Epitope Diagnostics, Inc.
10.2.9. OPERON, S.A.
10.2.10. R-Biopharm AG
10.2.11. Svar Life Science
10.2.12. Thermo Fisher Scientific Inc.
10.2.13. Werfen
10.2.14. SENTINEL CH. SpA
10.2.15. Diazyme Laboratories, Inc.
10.2.16. DiAgam
10.2.17. Other Prominent Players
Fecal Calprotectin Test Market- By Patient Type
Fecal Calprotectin Test Market- By Assay Type
Fecal Calprotectin Test Market- By Indication
Fecal Calprotectin Test Market- By End-User
Fecal Calprotectin Test Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
